DGAP-CMS: Wacker Neuson SE: Release of a capital market information
2021. május 17., hétfő, 15:44
Wacker Neuson SE, Munich Share buyback: Disclosure pursuant to Article 5 sec. 1 lit. b) and sec. 3 of Regulation (EU) No 596/2014 and Art. 2 sec. 2 and 3 of Commission Delegated Regulation (EU) No 2016/1052 Acquisition of treasury shares - interim report 7 In the period from May 10, 2021 up to and including May 14, 2021 a total of 77,500 shares were acquired as part of the Share Buyback Program 2021. The start of the Share Buyback Program 2021 was announced in a notice dated March 29, 2021 pursuant to Art. 5 of Regulation (EU) No 596/2014 (Market Abuse Regulation) and pursuant to Art. 2 sec. 1 of Commission Delegated Regulation (EU) No 2016/1052 of March 8, 2016. The total number of shares repurchased in the period from May 10, 2021 up to and including
The total number of shares, repurchased during the Share Buyback Program 2021 so far, amounts to 599,900 pieces of shares. The share buyback is carried out by a credit institution, commissioned by Wacker Neuson SE, exclusively via the Stock Exchange in the electronic Xetra-trading system. Information about each transaction as well as the daily trading volume are published pursuant to Art. 5 of Regulation (EU) No. 596/2014 (Market Abuse Regulation) and pursuant to Commission Delegated Regulation (EU) No 2016/1052 on the internet under the following link: https://wackerneusongroup.com/en/investor-relations/shares/share-buyback Munich, May 17, 2021 Wacker Neuson SE
|
Language: | English |
Company: | Wacker Neuson SE |
Preußenstr. 41 | |
80809 München | |
Germany | |
Internet: | www.wackerneusongroup.com |
End of News | DGAP News Service |
1197400 17.05.2021
Közzétételek - archívum
-
» Laxxon Medical to Participate in the BIO CEO & Investor Conference
[2023.02.02. 20:15]
-
» PJSC Magnitogorsk Iron and Steel Works: MMK notifies on additional extension of consent solicitation process
[2022.06.30. 13:00]
-
» Evonik Industries and Laxxon Medical see future in 3D screen printed pharmaceuticals
[2022.03.08. 15:02]
-
» Evonik und Laxxon Medical sehen Zukunftsmarkt für 3D-Druck von Tabletten
[2022.03.08. 15:02]
-
» "Game Changing" Technology Enables QR Code Integration with 3D Screen Printing
[2022.02.16. 17:31]
-
» Laxxon Medical to Participate in the 24th Annual Needham Virtual Growth Conference
[2022.01.07. 16:40]
-
» EQS-News: Focus Financial Partners Announces the Launch of Beryllus Capital in a Leading-Edge Joint Venture with the Hinduja Group
[2021.03.22. 12:45]
-
» DGAP-Adhoc: TRATON SE: TRATON und Navistar einig über Fortsetzung der Gespräche
[2020.10.16. 18:43]
-
» DGAP-Adhoc: TRATON SE: TRATON and Navistar agreement in principle
[2020.10.16. 18:43]